BRPI0410642A - processo para sintetizar intermediários de inibidor de betailactamase - Google Patents

processo para sintetizar intermediários de inibidor de betailactamase

Info

Publication number
BRPI0410642A
BRPI0410642A BRPI0410642-3A BRPI0410642A BRPI0410642A BR PI0410642 A BRPI0410642 A BR PI0410642A BR PI0410642 A BRPI0410642 A BR PI0410642A BR PI0410642 A BRPI0410642 A BR PI0410642A
Authority
BR
Brazil
Prior art keywords
lactamase inhibitor
beta
synthesizing beta
inhibitor intermediates
lactamase
Prior art date
Application number
BRPI0410642-3A
Other languages
English (en)
Inventor
Ramesh Venkat Matur
Mark Edward Ruppen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0410642A publication Critical patent/BRPI0410642A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"PROCESSO PARA SINTETIZAR INTERMEDIáRIOS DE INIBIDOR DE BETA-LACTAMASE". A presente invenção refere-se a um processo enzimático para a produção de um composto intermediário, o ácido heteroaril-2-carboxílico bicíclico de fórmula (I), em que X e Y são como definidos no relatório descritivo, cujo composto é de utilidade na preparação de inibidores de beta-lactamase, mediante hidrólise enzimática seletiva de uma mistura de ésteres hidrolizáveis posicionais de fórmulas (II) e (III), onde X, Y e R são como definido no relatório descritivo.
BRPI0410642-3A 2003-05-16 2004-05-12 processo para sintetizar intermediários de inibidor de betailactamase BRPI0410642A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47146103P 2003-05-16 2003-05-16
PCT/US2004/014833 WO2004104008A1 (en) 2003-05-16 2004-05-12 PROCESS FOR SYNTHESIZING β-LACTAMASE INHIBITOR INTERMEDIATES

Publications (1)

Publication Number Publication Date
BRPI0410642A true BRPI0410642A (pt) 2006-07-04

Family

ID=33476848

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410642-3A BRPI0410642A (pt) 2003-05-16 2004-05-12 processo para sintetizar intermediários de inibidor de betailactamase

Country Status (12)

Country Link
US (1) US7316917B2 (pt)
EP (1) EP1626972A1 (pt)
JP (1) JP2007501635A (pt)
CN (1) CN1823069A (pt)
AR (1) AR045681A1 (pt)
AU (1) AU2004240924A1 (pt)
BR (1) BRPI0410642A (pt)
CA (1) CA2525507A1 (pt)
CL (1) CL2004001037A1 (pt)
MX (1) MXPA05012113A (pt)
TW (1) TW200505925A (pt)
WO (1) WO2004104008A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276611B2 (en) * 2003-05-16 2007-10-02 Wyeth Holdings Corporation Process for synthesizing beta-lactamase inhibitor intermediates
ITRM20050345A1 (it) * 2005-06-30 2007-01-01 Sigma Tau Ind Farmaceuti Sintesi di deossi-biotinil esametilen diammina-dota.
WO2012045786A1 (de) 2010-10-07 2012-04-12 Basf Se Verfahren zur herstellung von ketonen, insbesondere makrocyclischer ketone
CN105274174A (zh) * 2015-11-30 2016-01-27 精晶药业股份有限公司 一种生物酶转化制备丙谷二肽的方法
CN110923288A (zh) * 2019-12-19 2020-03-27 卓和药业集团有限公司 一种wxfl10203614中间体的生物学拆分方法
WO2023284775A1 (zh) * 2021-07-14 2023-01-19 上海海雁医药科技有限公司 吡唑衍生物及其中间体和制备方法
CN117225399B (zh) * 2023-09-15 2025-09-02 中国科学技术大学 氧化亚锡作为人工金属蛋白酶的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496739A (en) * 1982-01-27 1985-01-29 Sumitomo Chemical Company, Limited Intermediates to optically active cis-1,3-dibenzyl-hexahydro-1H-furo[3,4-d]imidazole-2,4-dione
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
GB0106631D0 (en) * 2001-03-16 2001-05-09 Pfizer Ltd Pharmaceutically active compounds
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
US7276611B2 (en) 2003-05-16 2007-10-02 Wyeth Holdings Corporation Process for synthesizing beta-lactamase inhibitor intermediates

Also Published As

Publication number Publication date
EP1626972A1 (en) 2006-02-22
AU2004240924A1 (en) 2004-12-02
WO2004104008A1 (en) 2004-12-02
CL2004001037A1 (es) 2005-03-04
US7316917B2 (en) 2008-01-08
AR045681A1 (es) 2005-11-09
MXPA05012113A (es) 2006-02-08
CN1823069A (zh) 2006-08-23
TW200505925A (en) 2005-02-16
JP2007501635A (ja) 2007-02-01
CA2525507A1 (en) 2004-12-02
US20040229324A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
TNSN07465A1 (en) Organic compounds
ATE422200T1 (de) Verfahren zur herstellung substituierter nikotinsäureester
BRPI0410642A (pt) processo para sintetizar intermediários de inibidor de betailactamase
ATE343385T1 (de) Verfahren zur herstellung von donepezil
ATE532516T1 (de) Verfahren zur synthese von glyt-1-hemmern
ATE441627T1 (de) Verfahren zur herstellung von valsartan
BRPI0507422A (pt) processo para produção de ácido 2,5-dimetilfenilacético
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
ATE495158T1 (de) Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
BR0114647A (pt) Processo para a produção de composto de anilina substituìda
DE602007005077D1 (de) Verfahren zur Herstellung von Pyridinmethylsulphinylverbindungen
ATE399757T1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
DE602005010369D1 (de) 2-thiaquinolizidines als Glycosidase- und Glycosyltransferase-Inhibitoren
ATE486867T1 (de) Verfahren zur herstellung von hochreinem meloxicam und meloxicam-kaliumsalz
BRPI0413741A (pt) métodos para preparar thip e para preparar um composto, e, composto
UA93860C2 (ru) Способ получения пиразолов, способ региоселективного алкилирования и применение фосфата или фосфоната b способе
GB0320738D0 (en) Novel process
ATE427297T1 (de) Verfahren zur herstellung von beta- aminopropionsaurederivaten
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
BRPI0416663A (pt) processos para a preparação de ftalimidas n-substituìdas
ATE425972T1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
BR0313622A (pt) Processo para produção de um composto
BRPI0514313A (pt) processo para sintetizar um composto, e, composto
BRPI0508595A (pt) processo para a preparação de intermediários de cefalosporina usando ésteres do ácido alfa-iodo-1-azetidinaacético e trialquil-fosfitos
GT200200183A (es) Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]